Intelligent Monitoring System for Adaptive Medication Dosage in chronic disease management with the goal of reducing drug resistance and toxicity.

An Intelligent Monitoring System for Adaptive Medication Dosage was developed to improve diabetes care in elderly patients. The system integrates barcode-based drug identification, chemical property analysis, and machine learning to adjust dosages in real time according to current patient health data. By replacing static prescriptions with personalised, data-driven recommendations, the framework addresses challenges such as drug resistance, toxicity, and variable drug metabolism. Clinical testing demonstrated improved blood sugar control, reduced adverse reactions, and potential applications for managing other chronic diseases requiring complex medication regimens.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-08-08
DOI
https://doi.org/10.5281/zenodo.16777808
Primary Topic
Pharmaceutical Practices and Patient Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Intelligent Monitoring System for Adaptive Medication Dosage in chronic disease management with the goal of reducing drug resistance and toxicity.

Zenodo (CERN European Organization for Nuclear Research)
Pharmaceutical Practices and Patient Outcomes
article

Intelligent Monitoring System for Adaptive Medication Dosage in chronic disease management with the goal of reducing drug resistance and toxicity.

article en

Abstract

An Intelligent Monitoring System for Adaptive Medication Dosage was developed to improve diabetes care in elderly patients. The system integrates barcode-based drug identification, chemical property analysis, and machine learning to adjust dosages in real time according to current patient health data. By replacing static prescriptions with personalised, data-driven recommendations, the framework addresses challenges such as drug resistance, toxicity, and variable drug metabolism. Clinical testing demonstrated improved blood sugar control, reduced adverse reactions, and potential applications for managing other chronic diseases requiring complex medication regimens.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 47%
Pharmaceutical Practices and Patient Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.